Csl Limited Stock Today
| CMXHF Stock | USD 173.75 3.75 2.11% |
Performance0 of 100
| Odds Of DistressLess than 10
|
CSL is trading at 173.75 as of the 28th of November 2024. This is a 2.11 percent decrease since the beginning of the trading day. The stock's lowest day price was 173.75. CSL has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for CSL Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. The company has 482.22 M outstanding shares. More on CSL Limited
Moving together with CSL Pink Sheet
| 0.73 | NVO | Novo Nordisk AS | PairCorr |
| 0.72 | NONOF | Novo Nordisk AS | PairCorr |
| 0.88 | CSLLY | CSL | PairCorr |
| 0.82 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against CSL Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
CSL Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
CSL Limited [CMXHF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mega-Cap' category with a current market capitalization of 102.75 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CSL's market, we take the total number of its shares issued and multiply it by CSL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CSL Limited classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 482.22 M outstanding shares.
CSL Limited has accumulated about 10.44 B in cash with 2.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.67.
Check CSL Probability Of Bankruptcy
Ownership AllocationCSL holds a total of 482.22 Million outstanding shares. 30% of CSL Limited outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CSL Ownership Details
CSL Limited Risk Profiles
| Mean Deviation | 1.78 | |||
| Standard Deviation | 2.68 | |||
| Variance | 7.17 | |||
| Risk Adjusted Performance | (0.01) |
CSL Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in CSL without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
CSL Corporate Management
| Karen Etchberger | Executive VP of Quality and Bus. Services | Profile | |
| Paul McKenzie | Chief Officer | Profile | |
| BCom BComm | Chief Officer | Profile | |
| Wilfried Freudenberg | Department Production | Profile | |
| Christina Hickie | Sr Communications | Profile | |
| BS BS | Exec Counsel | Profile | |
| MS BA | Ex Officer | Profile |
Other Information on Investing in CSL Pink Sheet
CSL financial ratios help investors to determine whether CSL Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.